Pharmacogenomics of CYP2C9: Functional and Clinical Considerations†

Author： Daly Ann K.   Rettie Allan E.   Fowler Douglas M.   Miners John O.  

Publisher： MDPI

E-ISSN： 2075-4426|8|1|1-1

ISSN： 2075-4426

Source： Journal of Personalized Medicine, Vol.8, Iss.1, 2017-12, pp. : 1-1

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effects of H2S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat

By Wang Xianqin   Han Anyue   Wen Congcong   Chen Mengchun   Chen Xinxin   Yang Xuezhi   Ma Jianshe   Lin Guanyang  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24055-24063

MDPI

Access to resources Recommend Favorite

Effect of Exposure to Acute and Chronic High-Altitude Hypoxia on the Activity and Expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in Rats

By  

Pharmacology, Vol. 93, Iss. 1-2, 2014-02 ,pp. : 76-83

Karger

Access to resources Recommend Favorite

In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9

By Nembri Serena   Grisoni Francesca   Consonni Viviana   Todeschini Roberto  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-06 ,pp. : 914-914

MDPI

Access to resources Recommend Favorite

Effect of CYP2C9 Genetic Polymorphism in a Chinese Population on the Metabolism of Mestranol in vitro

By  

Pharmacology, Vol. 95, Iss. 5-6, 2015-04 ,pp. : 218-223

Karger

Access to resources Recommend Favorite

Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitro

By  

Pharmacology, Vol. 98, Iss. 3-4, 2016-06 ,pp. : 183-189

Karger

Access to resources Recommend Favorite